CLINICAL_TRIALS
trial_result
· 2022-11-09
Clinical Trial Update: Intravitreal Faricimab in Diabetic Macular Edema With Limited Response to Aflibercept [Phase 4]
Summary
Phase 4 clinical trial update evaluating intravitreal faricimab in patients with diabetic macular edema who show limited response to aflibercept.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vista Klinik | Conditions: Diabetic Macular Edema | Phase 4 | Status: UNKNOWN